Philip D. Gregory
2019 - bluebird bio
In 2019, Philip D. Gregory earned a total compensation of $3.9M as Chief Scientific Officer at bluebird bio, a 55% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $194,600 |
---|---|
Option Awards | $2,348,552 |
Salary | $455,000 |
Stock Awards | $908,753 |
Other | $11,200 |
Total | $3,918,105 |
Gregory received $2.3M in option awards, accounting for 60% of the total pay in 2019.
Gregory also received $194.6K in non-equity incentive plan, $455K in salary, $908.8K in stock awards and $11.2K in other compensation.
Rankings
In 2019, Philip D. Gregory's compensation ranked 3,062nd out of 13,971 executives tracked by ExecPay. In other words, Gregory earned more than 78.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,062 out of 13,971 | 78th |
Division Manufacturing | 1,104 out of 5,701 | 81st |
Major group Chemicals And Allied Products | 371 out of 2,200 | 83rd |
Industry group Drugs | 305 out of 1,886 | 84th |
Industry Biological Products, Except Diagnostic Substances | 72 out of 389 | 82nd |
Source: SEC filing on April 27, 2020.
Gregory's colleagues
We found five more compensation records of executives who worked with Philip D. Gregory at bluebird bio in 2019.